These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 23073336)
1. Effects of tiotropium on lung function in severe asthmatics with or without emphysematous changes. Yoshida M; Nakano T; Fukuyama S; Matsumoto T; Eguchi M; Moriwaki A; Takata S; Machida K; Kanaya A; Matsumoto K; Nakanishi Y; Inoue H Pulm Pharmacol Ther; 2013 Apr; 26(2):159-66. PubMed ID: 23073336 [TBL] [Abstract][Full Text] [Related]
2. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. Kerstjens HA; Disse B; Schröder-Babo W; Bantje TA; Gahlemann M; Sigmund R; Engel M; van Noord JA J Allergy Clin Immunol; 2011 Aug; 128(2):308-14. PubMed ID: 21636120 [TBL] [Abstract][Full Text] [Related]
3. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma. Fardon T; Haggart K; Lee DK; Lipworth BJ Respir Med; 2007 Jun; 101(6):1218-28. PubMed ID: 17178217 [TBL] [Abstract][Full Text] [Related]
4. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M; N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213 [TBL] [Abstract][Full Text] [Related]
5. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD. Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763 [TBL] [Abstract][Full Text] [Related]
6. Effects of tiotropium on lung function in current smokers and never smokers with bronchial asthma. Yoshida M; Kaneko Y; Ishimatsu A; Komori M; Iwanaga T; Inoue H Pulm Pharmacol Ther; 2017 Feb; 42():7-12. PubMed ID: 27888045 [TBL] [Abstract][Full Text] [Related]
7. Tiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: a randomised dose-ranging study. Vogelberg C; Engel M; Moroni-Zentgraf P; Leonaviciute-Klimantaviciene M; Sigmund R; Downie J; Nething K; Vevere V; Vandewalker M Respir Med; 2014 Sep; 108(9):1268-76. PubMed ID: 25081651 [TBL] [Abstract][Full Text] [Related]
8. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group. Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576 [TBL] [Abstract][Full Text] [Related]
9. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. Bateman ED; Kornmann O; Schmidt P; Pivovarova A; Engel M; Fabbri LM J Allergy Clin Immunol; 2011 Aug; 128(2):315-22. PubMed ID: 21807250 [TBL] [Abstract][Full Text] [Related]
10. Additive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroids. Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW Respirology; 2006 Sep; 11(5):598-602. PubMed ID: 16916333 [TBL] [Abstract][Full Text] [Related]
11. Acute effects of indacaterol on lung hyperinflation in moderate COPD: a comparison with tiotropium. Rossi A; Centanni S; Cerveri I; Gulotta C; Foresi A; Cazzola M; Brusasco V Respir Med; 2012 Jan; 106(1):84-90. PubMed ID: 22035851 [TBL] [Abstract][Full Text] [Related]
12. Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: the BRIGHT study. Beeh KM; Korn S; Beier J; Jadayel D; Henley M; D'Andrea P; Banerji D Respir Med; 2014 Apr; 108(4):584-92. PubMed ID: 24534204 [TBL] [Abstract][Full Text] [Related]
13. A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD. Cazzola M; Andò F; Santus P; Ruggeri P; Di Marco F; Sanduzzi A; D'Amato M Pulm Pharmacol Ther; 2007; 20(5):556-61. PubMed ID: 16914336 [TBL] [Abstract][Full Text] [Related]
14. Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study. Bateman ED; van Dyk M; Sagriotis A Pulm Pharmacol Ther; 2008; 21(1):20-5. PubMed ID: 17118684 [TBL] [Abstract][Full Text] [Related]
15. Onset of effect of aclidinium, a novel, long-acting muscarinic antagonist, in patients with COPD. Vestbo J; Vogelmeier C; Creemers J; Falques M; Ribera A; Gil EG COPD; 2010 Oct; 7(5):331-6. PubMed ID: 20854047 [TBL] [Abstract][Full Text] [Related]
16. Bronchodilator responsiveness in patients with COPD. Tashkin DP; Celli B; Decramer M; Liu D; Burkhart D; Cassino C; Kesten S Eur Respir J; 2008 Apr; 31(4):742-50. PubMed ID: 18256071 [TBL] [Abstract][Full Text] [Related]
17. Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial. Troosters T; Celli B; Lystig T; Kesten S; Mehra S; Tashkin DP; Decramer M; Eur Respir J; 2010 Jul; 36(1):65-73. PubMed ID: 20185426 [TBL] [Abstract][Full Text] [Related]
18. Lack of protective effect of tiotropium vs induced dynamic hyperinflation in moderate COPD. Gelb AF; Fraser C; Zamel N Respir Med; 2011 May; 105(5):755-60. PubMed ID: 21159499 [TBL] [Abstract][Full Text] [Related]
19. Tiotropium in asthma poorly controlled with standard combination therapy. Kerstjens HA; Engel M; Dahl R; Paggiaro P; Beck E; Vandewalker M; Sigmund R; Seibold W; Moroni-Zentgraf P; Bateman ED N Engl J Med; 2012 Sep; 367(13):1198-207. PubMed ID: 22938706 [TBL] [Abstract][Full Text] [Related]
20. Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison. Mahler DA; D'Urzo A; Bateman ED; Ozkan SA; White T; Peckitt C; Lassen C; Kramer B; Thorax; 2012 Sep; 67(9):781-8. PubMed ID: 22544891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]